Drug Safety / Pharmacovigilance    

Websites:    

Canada

• Canadian Adverse Drug Reaction Newsletter (CARN) (Health Canada)
• Drugs and Health Products (Health Canada)
  
• Expert Advisory Committee on the Vigilance of Health Products (Health Canada)
  

United States

• Agency for Healthcare Research and Quality (AHRQ) (U.S. Department of Health & Human Services) 
• Medical Errors and Patient Safety (U.S. Department of Health & Human Services)
• Medication Guides (U.S. Food and Drug Administration)
• Medicines Quality Database (MQDB) (U.S. Pharmacopeia)
  
• MedWatch: The FDA Medical Products Reporting Program (U.S. Food and Drug Administration)
  
• Postmarketing Drug Safety Evaluations (U.S. Food and Drug Administration)

United Kingdom

• Committee on Safety of Medicines (CSM) (United Kingdom Department of Health)
• Current Problems in Pharmacovigilance (United Kingdom Department of Health)
• Medicines and Healthcare Products Regulatory Agency (MHRA) (United Kingdom Department of Health) 
• Safety Information (United Kingdom Department of Health)

International

• Adverse Reaction (ADR) Newsletter (Beginning in the year 2000, this newsletter was incorporated in the WHO Pharmaceuticals Newsletter)
• Agence Francaise de Securite Sanitaire des Produits de Sante (French Medicines Agency)
• France Ministry of Health 
• New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE)
• Swedish Medical Products Agency
• The Uppsala Monitoring Centre (UMC) (WHO Collaborating Centre for International Drug Monitoring)
• Therapeutic Goods Administration (TGA) (Australian Government Department on Health and Ageing) 
• WHO Pharmaceuticals Newsletter

Organizations   

Websites:   

• Health Action International (HAI)
• Institute for Safe Medication Practices (ISMP)
• Institute for Safe Medication Practices Canada (ISMP-Canada)
• Institute of Medicine (IOM) of the National Academies
• International Society for Pharmacoepidemiology (ISPE)
• National Patient Safety Foundation (NPSF)
• National Quality Forum (NQF)
• National System for Incident Reporting (NSIR) (Canadian Institute for Health Information)
• SafeMedicationUse.ca (ISMP Canada)
  
• U.K. Drug Safety Research Unit (DSRU)
• U.S. Pharmacopeia (USP)

Recommended texts are linked to publishers' or book sellers' websites for further    ordering information:

• Dictionary of Pharmacovigilance (Alghabban, 2004) - $

Dynamic Searches:   

Please follow these links to search PubMed for the latest:

• Citations in which the MeSH for drug safety – Drug Toxicity – is combined using AND with either the textword pharmacovigilance or the textword phrase “drug safety”.
• Citations in which the textword pharmacovigilance or the textword phrase “drug safety” appear in journal article titles.
• Citations in which the MeSH  - Adverse Drug Reaction Reporting Systems - is a major concept.
• Citations in which the MeSH for post-marketing surveillance – Product Surveillance, Postmarketing – is a major concept.

 $ - Resource is not freely available on the Internet